MELLONE, MANUELA
MELLONE, MANUELA
Dipartimento di Scienze Farmacologiche e Biomolecolari
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit
2016 A. Tozzi, A. de Iure, V. Bagetta, M. Tantucci, V. Durante, A. Quiroga Varela, C. Costa, M. Di Filippo, V. Ghiglieri, E.C. Latagliata, M. Wegrzynowicz, M. Decressac, C. Giampà, J.W. Dalley, J. Xia, F. Gardoni, M. Mellone, O.M. El Agnaf, M.T. Ardah, S. Puglisi Allegra, A. Björklund, M.G. Spillantini, B. Picconi, P. Calabresi
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration
2019 V. Durante, A. de Iure, V. Loffredo, N. Vaikath, M. De Risi, S. Paciotti, A. Quiroga-Varela, D. Chiasserini, M. Mellone, P. Mazzocchetti, V. Calabrese, F. Campanelli, A. Mechelli, M. Di Filippo, V. Ghiglieri, B. Picconi, O.M. El-Agnaf, E. De Leonibus, F. Gardoni, A. Tozzi, P. Calabresi
Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target
2017 B. Borroni, J. Stanic, C. Verpelli, M. Mellone, E. Bonomi, A. Alberici, P. Bernasconi, L. Culotta, E. Zianni, S. Archetti, M. Manes, S. Gazzina, R. Ghidoni, L. Benussi, C. Stuani, M. Di Luca, C. Sala, E. Buratti, A. Padovani, F. Gardoni
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure.
2020 F. Palese, E. Bonomi, T. Nuzzo, A. Benussi, M. Mellone, E. Zianni, F. Cisani, A. Casamassa, A. Alberici, D. Scheggia, A. Padovani, E. Marcello, M. Di Luca, A. Pittaluga, A. Usiello, B. Borroni, F. Gardoni
Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications
2018 M. Mellone, F. Gardoni
Linking NMDA Receptor Synaptic Retention to Synaptic Plasticity and Cognition
2019 L. Franchini, J. Stanic, L. Ponzoni, M. Mellone, N. Carrano, S. Musardo, E. Zianni, G. Olivero, E. Marcello, A. Pittaluga, M. Sala, C. Bellone, C. Racca, M. Di Luca, F. Gardoni
LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias
2016 J. Stanic, M. Mellone, M.D. Cirnaru, M. Perez-Carrion, E. Zianni, M.M.G. Di Luca, F. Gardoni, G. Piccoli
Modulation of NMDA receptor at the synapse: Promising therapeutic interventions in disorders of the nervous system
2013 M. Mellone, F. Gardoni
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia : Behavioral, molecular, and synaptic mechanisms
2016 V. Ghiglieri, D. Mineo, A. Vannelli, F. Cacace, M. Mancini, V. Pendolino, F. Napolitano, A. di Maio, M. Mellone, J. Stanic, E. Tronci, C. Fidalgo, R. Stancampiano, M. Carta, P. Calabresi, F. Gardoni, A. Usiello, B. Picconi
Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine : implications for reparative therapy in Parkinson's disease
2012 L. Cova, P. Bossolasco, M.T. Armentero, V. Diana, E. Zennaro, M. Mellone, C. Calzarossa, S. Cerri, G. Lambertenghi-Deliliers, E. Polli, F. Blandini, V. Silani
NMDA receptor gluN2A/gluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias : from experimental models to patients
2015 M. Mellone, J. Stanic, L.F. Hernandez, E. Iglesias, E. Zianni, A. Longhi, A. Prigent, B. Picconi, P. Calabresi, E.C. Hirsch, J.A. Obeso, M. Di Luca, F. Gardoni
NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology
2019 M. Mellone, E. Zianni, J. Stanic, F. Campanelli, G. Marino, V. Ghiglieri, A. Longhi, M.L. Thiolat, Q. Li, P. Calabresi, E. Bezard, B. Picconi, M. Di Luca, F. Gardoni
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
2015 M.F. Bastide, W.G. Meissner, B. Picconi, S. Fasano, P. Fernagut, M. Feyder, V. Francardo, C. Alcacer, Y. Ding, R. Brambilla, G. Fisone, A. Jon Stoessl, M. Bourdenx, M. Engeln, S. Navailles, P. De Deurwaerdère, W.K.D. Ko, N. Simola, M. Morelli, L. Groc, M. Rodriguez, E.V. Gurevich, M. Quik, M. Morari, M. Mellone, F. Gardoni, E. Tronci, D. Guehl, F. Tison, A.R. Crossman, U.J. Kang, K. Steece-Collier, S. Fox, M. Carta, M.A. Cenci, E. Bézard
Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target
2018 B. Borroni, J. Stanic, C. Verpelli, M. Mellone, E. Bonomi, A. Alberici, P. Bernasconi, L. Culotta, E. Zianni, S. Archetti, M. Manes, S. Gazzina, R. Ghidoni, L. Benussi, C. Stuani, M. Di Luca, C. Sala, E. Buratti, A. Padovani, F. Gardoni
Ring finger protein 10 is a novel synaptonuclear messenger encoding activation of NMDA receptors in hippocampus
2016 M.C. Dinamarca, F. Guzzetti, A. Karpova, D. Lim, N. Mitro, S. Musardo, M. Mellone, E. Marcello, J. Stanic, T. Samaddar, A. Burguière, A. Caldarelli, A.A. Genazzani, J. Perroy, L. Fagni, P.L. Canonico, M.R. Kreutz, F. Gardoni, M.M.G. Di Luca
Safinamide modulates striatal glutamatergic signalling in a rat model of levodopa-induced dyskinesia
2018 F. Gardoni, M. Morari, J. Kulisevsky, A. Brugnoli, S. Novello, C.A. Pisano, C. Caccia, M. Mellone, E. Melloni, G. Padoani, V. Sosti, S. Vailati, C. Keywood
Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies
2013 M. Mellone, D. Kestoras, M.R. Andrews, E. Dassie, R.A. Crowther, G.B. Stokin, J. Tinsley, G. Horne, M. Goedert, A.M. Tolkowsky, M.G. Spillantini
Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat
2010 F. Blandini, L. Cova, M.T. Armentero, E. Zennaro, G. Levandis, P. Bossolasco, C. Calzarossa, M. Mellone, G. Busca, G. Lambertenghi Deliliers, E. POlli, G. Nappi, V. Silani
Zinc transporter-1: a novel NMDA receptor-binding protein at the postsynaptic density
2015 M. Mellone, S. Pelucchi, L. Alberti, A. Genazzani, M. Di Luca, F. Gardoni